Literature DB >> 21184274

PALB2 germline mutations in familial breast cancer cases with personal and family history of pancreatic cancer.

Paolo Peterlongo, Irene Catucci, Graziella Pasquini, Paolo Verderio, Bernard Peissel, Monica Barile, Liliana Varesco, Mirko Riboni, Stefano Fortuzzi, Siranoush Manoukian, Paolo Radice.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 21184274     DOI： 10.1007/s10549-010-1305-1

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN： 0167-6806            Impact factor:   4.872


× No keyword cloud information.
  17 in total

1.  Routine testing for PALB2 mutations in familial pancreatic cancer families and breast cancer families with pancreatic cancer is not indicated.

Authors:  Femme Harinck; Irma Kluijt; Saskia E van Mil; Quinten Waisfisz; Theo A M van Os; Cora M Aalfs; Anja Wagner; Maran Olderode-Berends; Rolf H Sijmons; Ernst J Kuipers; Jan-Werner Poley; Paul Fockens; Marco J Bruno
Journal:  Eur J Hum Genet       Date:  2011-12-14       Impact factor: 4.246

2.  Novel germline PALB2 truncating mutations in African American breast cancer patients.

Authors:  Yonglan Zheng; Jing Zhang; Qun Niu; Dezheng Huo; Olufunmilayo I Olopade
Journal:  Cancer       Date:  2011-08-26       Impact factor: 6.860

3.  Germline mutations in BRIP1 and PALB2 in Jewish high cancer risk families.

Authors:  Irene Catucci; Roni Milgrom; Anya Kushnir; Yael Laitman; Shani Paluch-Shimon; Sara Volorio; Filomena Ficarazzi; Loris Bernard; Paolo Radice; Eitan Friedman; Paolo Peterlongo
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

4.  Analysis of PALB2 in a cohort of Italian breast cancer patients: identification of a novel PALB2 truncating mutation.

Authors:  Maria Teresa Vietri; Gemma Caliendo; Concetta Schiano; Amelia Casamassimi; Anna Maria Molinari; Claudio Napoli; Michele Cioffi
Journal:  Fam Cancer       Date:  2015-09       Impact factor: 2.375

Review 5.  Inherited pancreatic cancer.

Authors:  Fei Chen; Nicholas J Roberts; Alison P Klein
Journal:  Chin Clin Oncol       Date:  2017-12

6.  Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy.

Authors:  P Ghiorzo; V Pensotti; G Fornarini; S Sciallero; L Battistuzzi; F Belli; L Bonelli; G Borgonovo; W Bruno; A Gozza; S Gargiulo; L Mastracci; S Nasti; G Palmieri; F Papadia; L Pastorino; A Russo; V Savarino; L Varesco; L Bernard; G Bianchi Scarrà
Journal:  Fam Cancer       Date:  2012-03       Impact factor: 2.375

Review 7.  Is it time to split strategies to treat homologous recombinant deficiency in pancreas cancer?

Authors:  Min Yuen Teo; Eileen M O'Reilly
Journal:  J Gastrointest Oncol       Date:  2016-10

8.  Mutation screening of PALB2 in clinically ascertained families from the Breast Cancer Family Registry.

Authors:  Tú Nguyen-Dumont; Fleur Hammet; Maryam Mahmoodi; Helen Tsimiklis; Zhi L Teo; Roger Li; Bernard J Pope; Mary Beth Terry; Saundra S Buys; Mary Daly; John L Hopper; Ingrid Winship; David E Goldgar; Daniel J Park; Melissa C Southey
Journal:  Breast Cancer Res Treat       Date:  2015-01-10       Impact factor: 4.872

Review 9.  Emerging frontiers in pancreatic cancer research: elaboration of key genes, cells and the extracellular milieu.

Authors:  Chandan Kumar-Sinha; Iris Wei; Diane M Simeone
Journal:  Curr Opin Gastroenterol       Date:  2012-09       Impact factor: 3.287

10.  Characterization of a novel germline PALB2 duplication in a hereditary breast and ovarian cancer family.

Authors:  Ciyu Yang; Angela G Arnold; Magan Trottier; Yukio Sonoda; Nadeem R Abu-Rustum; Oliver Zivanovic; Mark E Robson; Zsofia K Stadler; Michael F Walsh; David M Hyman; Kenneth Offit; Liying Zhang
Journal:  Breast Cancer Res Treat       Date:  2016-10-18       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.